I personally am not putting too much emphasis/expectations on the last quarter in the US.. I think Q1 2016-17 will be the one that will re-rate.. happy to be wrong.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”